Login
$CVSA
$117.74 +$0.00 (0.0%) After hours

$CVSA 8-K SEC Filings

Filed On Filing
29 Oct 2026 8-K: Results of Operations and Financial Condition

Diluted earnings per share $1.95; Adjusted EPS $2.19, growth of 25.1% YoY

23 Sep 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation

Execution Version AMENDMENT NO. 6 TO CREDIT AGREEMENT This AMENDMENT NO. 6 TO CREDIT AGREEMENT (this “Agreement”), dated as of September 18, 2026, is made by and among Covista Inc., a Delaware corporation (the “Borrower”), the Loan Parti...

06 Aug 2026 8-K: Results of Operations and Financial Condition

Fiscal year 2026 diluted earnings per share $7.04; Adjusted EPS $8.25, growth of 23.7% YoY

28 Jul 2026 8-K: Departure/Election of Directors or Officers; Compensation

Covista Names Emily C. Chiu and Leslie Storms to its Board of Directors Appointments Deepen the Board’s Expertise Across Healthcare Delivery, Technology, Higher Education and Veterinary Medicine Supports Effective Oversight of the Compan...

07 May 2026 8-K: Results of Operations and Financial Condition

Total enrollment up 6.8% YoY, with Chamberlain returning to positive total enrollment growth

09 Apr 2026 8-K: Regulation FD Disclosure

The U.S. healthcare workforce shortage requires more than just growing the supply through strong education, it also must solve the access problem, particularly in some of the most underserved areas like rural communities. This requires c...

03 Mar 2026 8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +1 more

Execution Version AMENDMENT NO. 5 TO CREDIT AGREEMENT AND INCREMENTAL ASSUMPTION AGREEMENT This AMENDMENT NO. 5 TO CREDIT AGREEMENT AND INCREMENTAL ASSUMPTION AGREEMENT (this “Agreement”), dated as of March 2, 2026, is made by and among ...

24 Feb 2026 8-K: Regulation FD Disclosure

Safe Harbor CAUTIONARY DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS Certain statements contained in this presentation are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking s...

06 Feb 2026 8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Regulation FD Disclosure

Section 1. The registered office of Covista Inc. (the “Corporation”) shall be in the City of Wilmington, County of New Castle, State of Delaware and the name and address of its registered agent is the Corporation Services Company, 251 Li...

28 Jan 2026 8-K: Results of Operations and Financial Condition

Investor Contact: Jay [email protected]+1 312-906-6600

15 Dec 2025 8-K: Other Events

New Three-Year, $750 Million Authorization Reflects Continued Confidence in Company's Fundamental Strength and Long-Term Strategic Outlook

14 Nov 2025 8-K: Submission of Matters to a Vote of Security Holders

On November 12, 2025, Adtalem held its Annual Meeting of Shareholders. The following tables present the final results of voting on each of the matters submitted to a vote of security holders during Adtalem’s Annual Meeting of Shareholders.

30 Oct 2025 8-K: Results of Operations and Financial Condition

Investor Contact: Jay Spitzer [email protected] +1 312-906-6600 Media Contact: Maureen Bender [email protected] +1 313-319-4732 ADTALEM GLOBAL EDUCATION FIRST QUARTER FISCAL YEAR 2026 RESULTS; MAINTAINS FISCAL YEAR 20...

07 Oct 2025 8-K: Other Events

CHICAGO – October 6, 2025 – Adtalem Global Education Inc. (NYSE: ATGE) today announced that Dr. Karen Cox will retire as president of Chamberlain University after nearly 40 years in healthcare and nursing education. Dr. Cox has led Chamb...

07 Aug 2025 8-K: Entry into a Material Definitive Agreement; Results of Operations and Financial Condition +1 more

Fiscal 2025 diluted earnings per share $6.18; Adjusted EPS $6.67, growth of 33.1% YoY

21 Jul 2025 8-K: Regulation FD Disclosure

On June 10, 2025, Stephen W. Beard, Chairman and Chief Executive Officer of Adtalem Global Education Inc. (the “Company”), entered into a written trading plan (the “10b5-1 Plan”), in accordance with Rule 10b5-1 under the Securities Excha...

08 May 2025 8-K: Results of Operations and Financial Condition

Diluted earnings per share $1.59; Adjusted EPS $1.92, growth of 28.0% YoY

06 May 2025 8-K: Other Events

Completes $300 million January 2024 Board-authorized share repurchase program

30 Jan 2025 8-K: Results of Operations and Financial Condition

Diluted earnings per share $1.98; Adjusted EPS $1.81, growth of 47.2% YoY

19 Nov 2024 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders

CHICAGO – Nov. 19, 2024 – Adtalem Global Education Inc. (NYSE: ATGE), the leading healthcare educator in the United States, today announced Steve Beard, president and chief executive officer, was unanimously elected by the Company’s boar...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support